awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745424-0C135386-61C0-47A2-B471-6D2771D10140
Q26745424-0C135386-61C0-47A2-B471-6D2771D10140
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-0C135386-61C0-47A2-B471-6D2771D10140
Nintedanib in NSCLC: evidence to date and place in therapy
P2860
Q26745424-0C135386-61C0-47A2-B471-6D2771D10140
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745424-0C135386-61C0-47A2-B471-6D2771D10140
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1864400b85f223161c06a4014736d83f3295965
P2860
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer.